Elanco Animal Health recently received conditional FDA approval for Credelio Quattro-CA1, the first companion animal treatment targeting New World screwworm infestations in dogs, reinforcing its ...

Conditional Approval Marks Elanco's Third New World Screwworm Treatment Option for Companion Animals, Providing Multiple Treatment Solutions Prior to Fly Being Detected in the U.S. FDA's Conditional ...

Company finalizing preparations for end of January 2026 U.S. FDA Biologics License Application (BLA) submission for OST-HER2 ...

State and federal officials are gearing up to stop the advance of a parasitic fly that is less than 70 miles from the United ...

A zone change request for a 35-acre property off U.S. 2 from Suburban to Commercial was unanimously approved by the Bonner ...

Perhaps some of the worst people to explain the real meaning of Christmas are those who claim to believe in its central ...

Officials for the FDA have expanded its’ approval of pimobendan chewable tablets (Vetmedin; Boehringer Ingelheim) to include a new indication. The drug is now approved for delay of congestive heart ...

Elanco's monoclonal antibody therapy, Trutect, received a conditional license from the federal agency in 2023.